Literature DB >> 25206269

Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis.

Mirko Tarocchi1, Simone Polvani1, Giada Marroncini1, Andrea Galli1.   

Abstract

Hepatitis B virus (HBV) infection is a global public health problem with approximately 2 billion people that have been exposed to the virus. HBV is a member of a family of small, enveloped DNA viruses called hepadnaviruses, and has a preferential tropism for hepatocytes of mammals and birds. Epidemiological studies have proved a strong correlation between chronic hepatitis B virus infection and the development of hepatocellular carcinoma (HCC). HCC is the fifth most common malignancy with about 700000 new cases each year, and more than 50% of them arise in HBV carriers. A large number of studies describe the way in which HBV can contribute to HCC development. Multiple mechanisms have been proposed, including the accumulation of genetic damage due to immune-mediated hepatic inflammation and the induction of oxidative stress. There is evidence of the direct effects of the viral proteins HBx and HBs on the cell biology. Integration of HBV-DNA into the human genome is considered an early event in the carcinogenic process and can induce, through insertional mutagenesis, the alteration of gene expression and chromosomal instability. HBV has also epigenetic effects through the modification of the genomic methylation status. Furthermore, the virus plays an important role in the regulation of microRNA expression. This review will summarize the many mechanisms involved in HBV-related liver carcinogenesis.

Entities:  

Keywords:  Cell biology; Chronic hepatitis B infection; Hepatitis B Virus; Hepatocarcinogenesis; Hepatocellular carcinoma

Mesh:

Substances:

Year:  2014        PMID: 25206269      PMCID: PMC4155355          DOI: 10.3748/wjg.v20.i33.11630

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  119 in total

1.  The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines.

Authors:  F Bergametti; S Prigent; B Luber; A Benoit; P Tiollais; A Sarasin; C Transy
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

2.  Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential.

Authors:  Z Rahmani; K W Huh; R Lasher; A Siddiqui
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: a role for HBV-induced HCC.

Authors:  Susanne Knoll; Katharina Fürst; Saijo Thomas; Sergio Villanueva Baselga; Anja Stoll; Stephanie Schaefer; Brigitte M Pützer
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

Review 4.  Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis.

Authors:  Mark A Feitelson; Jungmin Lee
Journal:  Cancer Lett       Date:  2006-12-22       Impact factor: 8.679

5.  Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.

Authors:  In Young Park; Bo Hwa Sohn; Eunsil Yu; Dong Jin Suh; Young-Hwa Chung; Je-Ho Lee; Stefan J Surzycki; Young Ik Lee
Journal:  Gastroenterology       Date:  2007-01-25       Impact factor: 22.682

6.  Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.

Authors:  Wing-Kin Sung; Hancheng Zheng; Shuyu Li; Ronghua Chen; Xiao Liu; Yingrui Li; Nikki P Lee; Wah H Lee; Pramila N Ariyaratne; Chandana Tennakoon; Fabianus H Mulawadi; Kwong F Wong; Angela M Liu; Ronnie T Poon; Sheung Tat Fan; Kwong L Chan; Zhuolin Gong; Yujie Hu; Zhao Lin; Guan Wang; Qinghui Zhang; Thomas D Barber; Wen-Chi Chou; Amit Aggarwal; Ke Hao; Wei Zhou; Chunsheng Zhang; James Hardwick; Carolyn Buser; Jiangchun Xu; Zhengyan Kan; Hongyue Dai; Mao Mao; Christoph Reinhard; Jun Wang; John M Luk
Journal:  Nat Genet       Date:  2012-05-27       Impact factor: 38.330

7.  Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment.

Authors:  Jianhua Li; Yinghui Liu; Zekun Wang; Kuancheng Liu; Yaohui Wang; Jiangxia Liu; Huanping Ding; Zhenghong Yuan
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

8.  Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.

Authors:  Qingqing Ding; Weiya Xia; Jaw-Ching Liu; Jer-Yen Yang; Dung-Fang Lee; Jiahong Xia; Geoffrey Bartholomeusz; Yan Li; Yong Pan; Zheng Li; Ralf C Bargou; Jun Qin; Chien-Chen Lai; Fuu-Jen Tsai; Chang-Hai Tsai; Mien-Chie Hung
Journal:  Mol Cell       Date:  2005-07-22       Impact factor: 17.970

Review 9.  Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers.

Authors:  M Tien Kuo; Niramol Savaraj
Journal:  Mol Carcinog       Date:  2006-09       Impact factor: 4.784

10.  Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Xufu Wei; Cui Tan; Chengyong Tang; Guosheng Ren; Tingxiu Xiang; Zhu Qiu; Rui Liu; Zhongjun Wu
Journal:  Cell Signal       Date:  2013-01-30       Impact factor: 4.315

View more
  66 in total

1.  Multi-omics in prognosis of hepatocellular carcinoma.

Authors:  Anna Lena Ress; Rishi Wagle; Martin Pichler
Journal:  Ann Transl Med       Date:  2015-01

Review 2.  Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies.

Authors:  Sayed Shahabuddin Hoseini; Nai-Kong V Cheung
Journal:  Cancer Lett       Date:  2017-04-17       Impact factor: 8.679

Review 3.  Molecular mechanisms of the preventable causes of cancer in the United States.

Authors:  Erica A Golemis; Paul Scheet; Tim N Beck; Eward M Scolnick; David J Hunter; Ernest Hawk; Nancy Hopkins
Journal:  Genes Dev       Date:  2018-06-26       Impact factor: 11.361

Review 4.  Virus-induced hepatocellular carcinoma with special emphasis on HBV.

Authors:  Ming Wang; Dong Xi; Qin Ning
Journal:  Hepatol Int       Date:  2017-01-17       Impact factor: 6.047

5.  Hepatitis B virus X protein promotes hepatocellular carcinoma invasion and metastasis via upregulating thioredoxin interacting protein.

Authors:  Zhiliang He; Youjia Yu; Yunhong Nong; Lingyao Du; Cong Liu; Yong Cao; Lang Bai; Hong Tang
Journal:  Oncol Lett       Date:  2017-06-01       Impact factor: 2.967

6.  SULF1/SULF2 reactivation during liver damage and tumour growth.

Authors:  Kurtis Graham; Joshua I Murphy; Gurtej K Dhoot
Journal:  Histochem Cell Biol       Date:  2016-03-25       Impact factor: 4.304

7.  Activation of AMPK/MnSOD signaling mediates anti-apoptotic effect of hepatitis B virus in hepatoma cells.

Authors:  Lei Li; Hong-Hai Hong; Shi-Ping Chen; Cai-Qi Ma; Han-Yan Liu; Ya-Chao Yao
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

8.  Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Dong-Hwan Jung; Shin Hwang; Ki-Hun Kim; Seung-Mo Hong; Young-Joo Lee; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Gil-Chun Park; Eun Sil Yu; Sung-Gyu Lee
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

Review 9.  Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma.

Authors:  Amy P Chiu; Barbara R Tschida; Lilian H Lo; Branden S Moriarity; Dewi K Rowlands; David A Largaespada; Vincent W Keng
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 10.  Hepatocarcinogenesis associated with hepatitis B, delta and C viruses.

Authors:  Elham Shirvani-Dastgerdi; Robert E Schwartz; Alexander Ploss
Journal:  Curr Opin Virol       Date:  2016-08-06       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.